S&P Futures
4,284.75 +8.00 (+0.19%) Dow Futures
34,011.00 +48.00 (+0.14%) Nasdaq Futures
13,520.50 +27.25 (+0.20%) Russell 2000 Futures
1,995.40 +6.30 (+0.32%) Crude Oil
89.13 +1.02 (+1.16%) Gold
1,784.70 +8.00 (+0.45%)
Zentek Ltd. (ZEN.V)
Chart Events
Performance Outlook
| Previous Close | 2.7300 |
| Open | 2.6800 |
| Bid | 2.5900 x 0 |
| Ask | 2.6000 x 0 |
| Day's Range | 2.5900 - 2.7500 |
| 52 Week Range | 2.1500 - 7.5000 |
| Volume | |
| Avg. Volume | 47,072 |
| Market Cap | 240.143M |
| Beta (5Y Monthly) | 1.02 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.3930 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.50 |
- ACCESSWIRE
Zentek Provides Update on Commercial Partnerships
Zentek Ltd.("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, provides the following updates on its commercial agreements relating to its proprietary ZenGUARD™ antimicrobial coating.
- ACCESSWIRE
Zentek Files a Provisional Patent on the use of ZenGUARD(TM) as an Anti-Inflammatory Agent
Zentek Ltd.("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, has filed a provisional patent on the use of ZenGUARD™ as an anti-inflammatory agent for dermatological conditions. "We continue to work diligently to secure patents for our various intellectual property," said Greg Fenton, CEO for Zentek.
- ACCESSWIRE
Zentek Announces Appointment of New Board Director
GUELPH, ON / ACCESSWIRE / July 5, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, welcomes Ilse Treurnicht to its Board of Directors.
